Production of the state of the art therapeutic radiopharmaceuticals in Iran, from beta- to alpha-emitting targeted radionuclide therapy: Clinical advances and perspectives

نویسندگان
doi
10.22034/irjnm.2023.129500.1595
چکیده

کلیدواژه‌ها
Esmail Jafari1, Majid Assadi1, Mohammad Eftekhari2, Alpha emitters, Radiopharmaceutical, Targeted therapy, Iran